Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

<p>Source Data</p>

Na minha lista:

Detalhes bibliográficos
Autor principal:	Takeru Oka (15386810) (author)
Outros Autores:	Tsunaki Higa (15386813) (author), Osamu Sugahara (15386816) (author), Daisuke Koga (15386819) (author), Shogo Nakayama (15386822) (author), Keiichi I. Nakayama (9625916) (author)
Publicado em:	2025
Assuntos:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Cell Cycle CDKs and CDK inhibitors Drug Resistance Novel mechanisms Gastrointestinal Cancers Colorectal cancer Stem Cell Biology Cancer stem cells Tumor Heterogeneity
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
Por: Takeru Oka (15386810)
Publicado em: (2025)

Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
Por: Emmanuel Griessinger (16721087)
Publicado em: (2025)

Table S2 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
Por: Emmanuel Griessinger (16721087)
Publicado em: (2025)

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Por: Xiaoqing Cheng (16918496)
Publicado em: (2025)

Table S2 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Por: Xiaoqing Cheng (16918496)
Publicado em: (2025)

Table S3 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Por: Xiaoqing Cheng (16918496)
Publicado em: (2025)

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Por: Xiaoqing Cheng (16918496)
Publicado em: (2025)

Table S5 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Por: Xiaoqing Cheng (16918496)
Publicado em: (2025)

Table S6 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
Por: Xiaoqing Cheng (16918496)
Publicado em: (2025)

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Por: Reza Mirzaei (15306062)
Publicado em: (2025)

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Por: Reza Mirzaei (15306062)
Publicado em: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
Por: Reza Mirzaei (15306062)
Publicado em: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
Por: Ana Vujovic (15207479)
Publicado em: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
Por: Lanpeng Chen (16918293)
Publicado em: (2025)

Table 2_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
Por: Sushmitha Rajeev Kumar (22687190)
Publicado em: (2025)

Table 1_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
Por: Sushmitha Rajeev Kumar (22687190)
Publicado em: (2025)

Video 2_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
Por: Minxia Ke (4889887)
Publicado em: (2025)

Data Sheet 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.docx
Por: Minxia Ke (4889887)
Publicado em: (2025)

Video 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
Por: Minxia Ke (4889887)
Publicado em: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
Por: Zhongyi Zhang (219440)
Publicado em: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
Por: Zhongyi Zhang (219440)
Publicado em: (2025)

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Por: Natalia Colomar-Carando (14611340)
Publicado em: (2025)

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Por: Natalia Colomar-Carando (14611340)
Publicado em: (2025)

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Por: Natalia Colomar-Carando (14611340)
Publicado em: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Por: Natalia Colomar-Carando (14611340)
Publicado em: (2025)

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
Por: Natalia Colomar-Carando (14611340)
Publicado em: (2025)

Cannot write session to /tmp/vufind_sessions/sess_qu50atjsnebr8uf2m4aus0hnc6